Virtus Biotech ETF
14 hedge funds and large institutions have $4.32M invested in Virtus Biotech ETF in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% more capital invested
Capital invested by funds: $4.32M → $4.32M ($0)
7% less funds holding
Funds holding: 15 → 14 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$913K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$282K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$106K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$40.6K |
| 5 |
FWM
Focused Wealth Management
Newburgh,
New York
|
+$7.92K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$561K |
| 2 |
Jane Street
New York
|
-$432K |
| 3 |
LPL Financial
San Diego,
California
|
-$397K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$216K |
| 5 |
VFS
VSR Financial Services
Overland Park,
Kansas
|
-$52K |
BBP Hedge Fund Activity: Q2 2016 in Review
14 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q2 2016, worth a combined $4.32M — unchanged from a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BBP and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.
The largest buyer was Royal Bank of Canada, adding an estimated $913K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $561K sold.
- 14 institutional investors held Virtus Biotech ETF (BBP) as of Q2 2016, down from 15 in Q1 2016.
- Funds reported $4.32M of Virtus Biotech ETF stock for Q2 2016, unchanged quarter-over-quarter.
- 3 funds opened new Virtus Biotech ETF positions in Q2 2016 and 4 closed out, a net change of -1 holder.
- The largest Virtus Biotech ETF buyer in Q2 2016 was Royal Bank of Canada, an estimated $913K added.
- The largest Virtus Biotech ETF seller in Q2 2016 was Virtu KCG Holdings, an estimated $561K sold.
Based on aggregated 13F filings for Q2 2016.